Socrates is right - veeegeee spews a pileveeegeee has a toxic relationship with facts. let's look at this morning's pile.
Kyocera announcement on the last day of the quarter signals that Q1 will be rough.
Already guided ~$45M from ITS. Wilan, ex Apple, is bonus.
How could they not pre-announce Apple signing if it was big?
In a way Apple has been pre-announced in the 04-FEB-2022 presser:
"Overall, we see the CAFC decision as favourable to WiLAN and consistent with the arguments heard at Oral Argument," said Michael Vladescu, President and CEO of WiLAN. "We remain committed and focused on advocating our positions which we believe are fair and balanced. At the same time, we always remain open to resolving any litigation disputes through reasonable negotiated solutions."
Expect the Apple results to be not out of line with the latest jury amount.
There is nothing to announce with Apple as McKool Smith and the Polaris partner took it all? McKool, for the 20th time, is contingency. There are NO POLARIS PARTNERS, as these patents were puchased by Wilan in 2016. CEO fired. If you read the AGM Circular, you may conclude that Paul Hill leaving was to transition to pure play ITS. His financial fortunes are still tied to QTRH future success. CFO fled to a penny stock. So! His position became obsolete with the pure play ITS decision. He stayed to complete year end matters. His choice of next career move is the subject for a different board. Vizio and Sharp handed attorney fees as case was deemed exceptional. Applied to only a small portion of the litigation, was accounted for in Q4 and probably got lost in rounding. ITS margins collapsed leading analysts to cut ITS estimates by 50%. The BIG lie - UNTRUE. The average target of the 5 analyst covering QTRH is $3.37, an 8.4% reduction from 3.68 prior to the release of the Q4 results. Specificallyy, Canaccord ($2.75 vs. $3.25), CIBC ($3.50 vs. $4.00), M Partners ($4.00 unchanged), Raymond James ($3.25 vs. $3.80) and Cormark ($3.35 unchanged). 4 directors walking the plank, including the chair and vice chair. UNTRUE - NO ONE IS WALKING A PLANK. 2 directors leaving in accordance with the corporate policy on term limits, a policy many have asked for for several years. Two directors to leave in 2023, again in accordance with the term limits policy. The two that are staying, Gillberry and Skippen, are knowledgeable on IP and will be important assets in the Wilan stratgegic review. The term limits implementation plan seems like good stewardship. Shareholder revolt = One large pile indeed Yes, the shareholder revolt claim is one pile indeed. Take the UNDER (4.43).